Two GTP binding regulatory proteins, Ns(Gs) and Ni(Gi), mediate the action of a number of hormones and other agents on adenylate cyclase. The proteins involved have been purified and studied in detail (1) . Cholera toxin ADP-ribosylates and activates Ns (2) . Pertussis toxin ADP-ribosylates and inactivates the inhibitory activity of Ni and the ability of transducin to mediate the light-induced activation of cyclic GMP (cGMP) phosphodiesterase in the retina (3, 4) . Pertussis toxin has been crystallized (5, 6 ) and purified to homogeneity (4) . Several observations suggest that GTP regulatory proteins may be involved in neutrophil activation. Ns has been demonstrated in neutrophils (7) , and incubation of neutrophils with cholera toxin increases their levels of cyclic AMP (cAMP) and inhibits their chemotactic responsiveness (8, 9) . It has been reported that nonhydrolyzable GTP analogues shift the affinity of the formylpeptide receptors of neutrophils (10) , and that the chemotactic peptide N-formyl-norleucyl-leucylphenylalanyl-leucyl-tyrosyl-lysine stimulates the GTPase activity of human neutrophil homogenates (11).
We therefore have tested the effect ofpretreatment of rabbit peritoneal neutrophils with crystalline pertussis toxin on granule enzyme secretion and chemotaxis induced by the chemotactic factors, formylmethionyl-leucyl-phenylalanine (fMet-Leu-Phe)', the fragment of the fifth component of complement (C5a), and the arachidonic acid metabolite, leukotriene B4 (LTB4), as well as on their stimulation by the calcium ionophore A23187 and phorbol 12-myristate 13-acetate (PMA). As we shall show, pretreatment with pertussis toxin inhibits chemotactic factor-induced chemotaxis and granule enzyme secretion from the neutrophil but has no effect on enzyme release caused by PMA or A23187. No detectable effect of toxin treatment is evident on the binding Abbreviations used in this paper. C5a, the fragment of the fifth component of complement; fMet-Leu-Phe, formylmethionyl-leucylphenylalanine; fNle-Leu-Phe, formylnodeucyl-leucyl-phenylalanine; LTB4, leukotriene B4 [5(S), 12(R)-dihydroxy-6, 14-cis 8, l0 trans eicosatetraenoic acid]; Ni and N,, two GTP binding regulatory proteins; PMA, phorbol 12-myristate-13 acetate.
of radiolabeled formylpeptides to their receptor or on the levels of neutrophil cAMP.
MATERIALS AND METHODS

Chemicals:
The synthetic peptides fMet-Leu-Phe and formylnodeucylleucyl-phenylalanine (fNle-Leu-Phe), A23187, 2 x crystalline ovalbumin, pnitrophenyl-N-acetyl-/3-o-glucosaminide, and shellfish glycogen were obtained from Sigma Chemical Co. (St. Louis, MO). The radiolabeled peptides, fMetLeu-[3H]Phe (48 Ci/mmol), fNle-Leu-[SH]Phe (42 Ci/mmol), and [3HlcAMP (37 Ci/mmol) were obtained from New England Nuclear (Boston, MA). CMC Cancer Research Chemicals was the source of the PMA, and LTB4 was a gift from Dr. P. Borgeat (Groupe de Recherches sur les Leucotrienes, Centre Hospitalier de rUniversite Laval, Sainte-Foy, Quebec, Canada). Highly purified C5a was a generous gift from Dr. P. M. Henson (National Jewish Hospital and Research Center, Denver, CO). The crystalline pertussis toxin was prepared and dissolved as described (5) .
Rabbit peritoneal neutrophils obtained 4-12 h after the injection of 200-400 ml of sterile 0. 1% shell fish glycogen were washed and treated as described (12) . For granule enzyme secretion, neutrophils were suspended at a concentration of 5 x l06 cells/ml in Mg2+-free modified Hanks' buffer with l mg/ml ovalbumin. They were incubated at 37"C with or without the indicated concentration of pertussis toxin; at the end of the indicated times, 0.94 ml of cell suspension was added to 50 tzl cytochalasin B and l0 ul of the stimulating compound, and the mixture was incubated for 5 min more. For chemotaxis, 2.5 x l06 cells/ml were incubated at 37"C for l h with or without toxin, and the chemotactic response was measured as indicated below.
Granule Enzyme Release: Granule enzyme release in the presence of 5 ug]ml of cytochalasin B was performed as previously described (12) and monitored by the assay of lysozyme and #-glucosaminidase. The lysozyme activity was determined by measuring the change in optical density of a suspension of Micrococcus lysodeikticus as described previously (12) . B-Glucosaminidase was measured by the breakdown of its substrate p-nitrophenyl-fl-N-acetyl glucosaminide as described (13) , except that a modification by D. L. Kreutzer was followed in which a 300-~1 aliquot was placed in a 96-well microtiter plate after the reaction was stopped, and the optical density was then determined at 410 nm with a Titertek Multiskan apparatus (Flow Laboratories, Inc., McLean, VA). The release of the two enzymes paralleled each other so that only the results for lysozyme are reported. The cells were also tested for lactic dehydrogenase leakage (12) . No increase was found even after a 90-min incubation at 37"C with pertussis toxin; therefore, lactate dehydrogenase results are not reported.
Chemotaxis:
Chemotaxis was carried out in a multichamber chemotaxis apparatus at 37"C for l h using 3-urn pore size filters, as described, except the chambers were not centrifuged (14) . The mean number of cells penetrating below the upper monolayer in five high-power fields (magnification of 400) was averaged over duplicate filters as a measure of the chemotactic response.
Receptor Binding: Studies of the binding of fMet-Leu-[3H]Phe and fNle-Leu-[3H]Phe to rabbit peritoneal neutrophils were performed by use of a modification of the silicone oil assay of Mackin et al. (15) . In brief, neutrophils obtained 4 b after injection of glycogen were washed twice with Mg2+-free, Ca 2÷ (1.7 mM)-containing Hanks' buffer and resuspended at 5 x 106 cells/ml in the same buffer that contained l mg/ml crystalline bovine serum albumin (Sigma Chemical Co.), Cells preincubated for 1 h at 37"C in the absence (control cells) or presence of 500 ng/ml pertussis toxin were centrifuged and resuspended to either 4 x l07 (fMet-Leu-[3HlPhe) or l x l0 a cells/ml (fNle-Leu-[3H]Phe). Dilutions of tritiated peptide from l0 -m to 2 x l0 -7 M were prepared in the same protein-containing buffer as the cells. Duplicate reaction mixtures for the binding assay were set up at 4"C by layering 50 ul of the various dilutions of tritiated peptide over 500 ul Versilube F50 silicone oil (General Electric, Silicone Products Division, Waterford, NY) in a microfuge tube. The binding reaction was started by the addition of 50 #l of the appropriate concentration of cells and stopped after 15 rain at 4"C by centrifugation in a microcentrifuge (model 235 A; Fisher Scientific Co., Pittsburgh, PA). Nonspecific binding was measured in the presence of a final concentration of l0 -5 M nonradioactive peptide. The free peptide and silicone oil were aspirated from each reaction tube, and the tip of the tube that contained the cells was excised. The cell pellet was dissolved in 200 ul of 88% formic acid, and the cells were counted in Rackbeta scintillation counter (model 1217; LKB Instruments, Gaithersburg, MD).
The binding data were analyzed using a version of the LIGAND computer program (16) To test the hypothesis that toxin treatment had no effect on the binding of the peptide, we analyzed each set of binding data individually, then the combined data from control and toxin-treated cells in each experiment. The results were considered not to contradict the hypothesis if the residual variance between the experimental data and the fitted curves showed no significant increase in a partial F test as a result of applying the constraints that the control and toxin-treated cells should exhibit equal binding capacities and affinities. Computer estimates of nonspecific binding were used throughout these analyses; however, these estimates did not differ significantly from the experimental values of nonspecific binding.
Measurement of cAMP:
The unstimulated and stimulated levels of intracellular cAMP in control and pertussis toxin-treated cells were measured as described previously (17) . Briefly, l-ml samples of washed cells (2 x l07 cells/ml) suspended in Hanks' buffer that contained 0.74 mM MgCl2 were added to 12 x 75 mm Falcon disposable plastic tubes (Falcon Labware, Oxnard, CA). The reaction was started by the addition of l0 -8 M fMet-Leu-Phe and stopped after l rain by the addition of 15.0 ul of 30% ice cold trichloroacetic acid. The denatured suspensions were frozen-thawed once. Approximately 0.07 pmol of 3[H]-cAMP was added to each sample for the determination of the recovery of cAMP. The samples were centrifuged at 2,400 g for 20 min, and l ml of the resulting supernatant was applied to a column 0.7 x 5 cm) of AG 50 W-X 8, H ÷ form, analytical grade cation-exchange resin, 200-400 mesh (Bio-Rad Laboratories, Richmond, CA) equilibrated with distilled water. The dried samples were reconstituted in 200 ul of 0.05 M sodium acetate buffer, pH 6.2 and to determine recovery, 50-~1 aliquots were removed for liquid scintillation counting (Delta 300; Searle Analytic Inc). Recovery of cAMP was generally 85-95% and was determined for every sample. Aliquots of 50-75 tal were assayed for total cAMP content by radioimmunoassay, which was performed according to the protocol for nonacetylated samples supplied in a double antibody precipitation kit (New England Nuclear).
RESULTS
Inhibition by Pertussis Toxin of Granule Enzyme Secretion by Chemotactic Factors
The action of pertussis toxin shows a latent period. Incubation of rabbit neutrophils with 10-1,000 ng/ml pertussis toxin for 20 min at 37"C had no discernible effect on the ability of fMet-Leu-Phe to induce secretion of lysozyme or flglucosaminidase (results not shown), whereas cells incubated longer were distinctly inhibited. Neutrophils pretreated with I0-1,000 ng/ml toxin for 45 min showed appreciable but submaximal inhibition of granule enzyme secretion (Fig. 1) ; at 60 min, the inhibition was indistinguishable from that obtained after a 90-min incubation (Fig. 1) . As seen in Fig. 1 , toxin treatment lowered the extent of release at every concentration of peptide tested. In the experiment pictured in Fig.  I , the inhibition was essentially complete in cells incubated with 200-1,000 ng/ml for 60 or 90 min. However, this varied somewhat among the four additional experiments performed; in some preparations of cells, inhibition was much more complete at 100 ng/ml than that shown in Fig. l , whereas other cells were somewhat less sensitive to the action of the toxin. However, in all experiments, 200 ng/ml invariably gave maximal inhibition after a 60-rain incubation. The results with #-glucosaminidase paralleled those with lysozyme, and there was no increase in lactic dehydrogenase leakage under any conditions of toxin treatment.
As is evident from Fig. 2 , pretreatment of neutrophils at 37"C for 60 min with 500 ng/ml toxin caused complete inhibition of granule enzyme secretion induced by C5a or LTB4. Despite appearances (Fig. 2) , when the corresponding curves were analyzed as described for the binding studies, the lower concentrations of LTB4 and C5a showed no significant differences in their ability to release enzyme from toxintreated and untreated cells. The same pattern as in Fig. 2 was seen in one additional experiment. 
Toxin Effect on Enzyme Release by PMA and A23187
As Fig. 3 demonstrates, incubation of rabbit neutrophils with 500 ng/ml toxin for 60 min at 37°C had no effect on lysozyme release induced by PMA. In the same experiment, toxin treatment completely abolished the secretagogue activity of fMet-Leu-Phe plus cytochalasin B. Chemotactic factors require cytochalasin B to release specific and azurophil granule contents from neutrophils in suspension, and cytochalasin B enhances release by A23187 (18) . PMA does not require cytochalasin B to induce release of specific granule constituents but does need it to induce the secretion of azurophil granule enzymes (19) . In the experiment pictured in Fig. 3 and in an additional experiment, cytochalasin B was not added to the PMA. In two other experiments not shown here, there was no inhibition of lysozyme or /3-glucosaminidase secretion from toxin-treated neutrophils in the presence of 5 #g/ml cytochalasin B and PMA. Thus, neither the presence nor absence of cytochalasin B affects the inability of pertussis toxin to inhibit enzyme release by PMA.
The calcium ionophore A23187 also induces granule enzyme secretion from rabbit neutrophils (18) . Incubation of rabbit neutrophils with 500 ng/ml toxin for 60 min at 37°C had no reproducible effect on either lysozyme release induced by A23187 (Fig. 4) or on glucosaminidase secretion (not shown). When the two curves of Fig. 2 were analyzed for equivalence essentially as described for the binding studies, the EDbo for the toxin-treated cells was 0.83 x l0 -6 M, whereas 
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The lack of effect of treating rabbit peritoneal neutrophils for 60 min at 37°C with 500 ng/ml of pertussis toxin on lysozyme secretion induced by PMA. The secretion was measured after a 25-min incubation at 37°C of neutrophils with PMA.
that for the untreated control was 1.2 x l0 -6 M, a small but statistically significant difference (P < 0.02). However, a second experiment done the same way did not confirm this result--the EDbo for the toxin-treated neutrophils was 4 x l0 -7 M, and that for the untreated control was 2.6 x 10 -7 (P > 0.1). The inhibition of chemotaxis induced by treating rabbit peritoneal neutrophils with 500 ng/ml pertussis toxin for 60 min at 37°C.
Toxin Inhibition of Chemotaxis
Leu-Phe. The sensitivity of the chemotactic reactivity to toxin treatment was at least as great as that of the granule enzyme secretory response and may be somewhat greater. The same results were seen in a duplicate experiment. Interestingly, there appeared to be no effect of toxin treatment on the penetration of the filter by the cells in the unstimulated buffer control.
Effect of Pertussis Toxin on FormyI Peptide Binding
Three studies of fNle-Leu-[3H]Phe-specific binding were performed to assess the effect of the pretreatment of rabbit neutrophils with 500 ng/ml pertussis toxin at 37"C for 60 min. Scatchard plots of formyl peptide binding in one typical study are shown in Fig. 6 . The Scatchard plots were invariably curved for both control and toxin-treated cells. Analysis by the LIGAND computer program indicated that the data were consistent with the binding of fNle-Leu-[3H]Phe to two independent sets of binding sites: the equilibrium dissociation constants (Kd) for these sites averaged 1.0 x 10 -9 and 1.2 x 10 -8 M and 8% of the sites, on average, were of the higher affinity. In the study illustrated (Fig. 6) , the fit to the complete experimental data for both control and toxin-treated cells was not significantly worsened (F = 1.29 with 4 and 20 degrees of freedom; P > 0.2) under the constraints that the binding capacities and affinities were unaffected by toxin treatment. Moreover, the experimental data points for both control and toxin-treated cells all lay within the 95% confidence limits around the constrained composite curve. Data from the other two studies with fNle-Leu-[3H]Phe showed the same pattern. crease in the other in the overall binding capacity appeared to occur after toxin treatment.
Effect of Pertussis Toxin on the Basal and fMetLeu-Phe-stimulated Levels of cAMP
We also examined the effect of pretreatment of rabbit neutrophils with toxin on the basal and fMet-Leu-Phe-stimulated rise in intracellular level of cAMP. The results summarized in Table I clearly show that the addition of toxin does not significantly affect the basal or the stimulated cAMP level.
DISCUSSION
The ability of pertussis toxin under the appropriate conditions to completely inhibit chemotaxis and granule enzyme secretion induced by the chemotactic factors, fMet-Leu-Phe, C5a, and LTB4 is strong evidence for the presence of a guanine nucleotide binding regulatory protein in the neutrophil identical with or analogous to Ni or to transducin. In an abstract that appeared as this work was being prepared for publication, Goldman et al. (20) reached a similar conclusion when they also found that pertussis toxin inhibits the activation of human neutrophils by chemotactic factors. More direct evidence for this conclusion are the unpublished findings ofF. Okajima and M. Ui (referred to in reference 21) and C. K. Huang of this institution, that pertussis toxin induces ADP-ribosylation of a 41-kD membrane protein from guinea pig and rabbit neutrophils, respectively. The inhibition of neutrophil activity by pertussis toxin is also strong evidence that the process or processes that this N protein regulates plays a necessary role in neutrophil function. The inhibition of both enzyme secretion and chemotaxis by pertussis toxin is concentration dependent and, most tellingly, its action requires a latent period.
Presumably, as in all other cells where it has been tested, the latent period is required for the pertussis toxin to bind to the cell and be internalized to exert its function. The neutrophil possesses a protein identical with or similar to Ns (7). Cholera toxin which acts through N, to raise cAMP levels inhibits stimulated neutrophil function (8, 9) . However, no matter what concentration of toxin or time of preincubation is used, the inhibition is never more than 40-50 %. This suggests that unlike the process regulated by the N protein susceptible to pertussis toxin, the neutrophil process or processes affected by Ns may not be absolutely required for cell function or that there are pathways involved in the cell functions that are independent of the latter. One possible mechanism of the inhibition is that the toxin treatment affects chemotactic receptor binding. Pertussis toxin treatment decreases the affinity of the D2 receptor for dopamine (22) and the c~2-adrenergic, the cholinergic, and opiate receptors for their respective ligands (23) . Garcia-Saenz et at. (24) have reported that pertussis toxin treatment induces a decreased formation of the high-affinity state for a2-adrenergic agonists. Neutrophils contain high-and low-affinity receptors for the formylpeptides (25, 26) , and guanine nucleotides have been reported to transform the high-affinity state of the formylpeptide receptor ofneutrophils and macrophages into a lower affinity state (10) . However, pertussis toxin treatment of neutrophils sufficient to completely inhibit the secretagogue action of fMet-Leu-Phe has no detectable effect on either the affinity or number of high-or low-affinity formylpeptide binding sites. This indicates that toxin treatment does not act on receptor binding but at some process or processes after receptor-chemotactic factor interaction. It is unknown whether the lack of effect of toxin treatment on receptor binding is because the putative N protein does not mediate changes in receptor affinity or whether, with the experimental conditions used, guanine nucleotide regulation of the binding site is nonexistent or not prominent.
In many cells, Ni is coupled to adenylate cyclase, and in these cells, treatment with pertussis toxin prevents the inhibition of adenylate cyclase which results from receptor-agonist interaction (3, 4) . This does not appear to be true of chemotactic factor-receptor interaction in neutrophils. Treatment of neutrophils with toxin under conditions that completely inhibit the ability of fMet-Leu-Phe to induce granule enzyme secretion has no significant effect on the level of cAMP in the same cells, fMet-Leu-Phe induces a rapid, transient increase in neutrophil intracellular cAMP (17, 27) which, however, is not required for the activation involved in granule secretion or the generation of 02- (28) . Toxin treatment of the neutrophils causes no change in the transient rise induced by fMetLeu-Phe. Although it is not known whether the receptormediated rise of cAMP occurs through the activation of adenylate cyclase, this finding does emphasize that the effect of pertussis toxin is not mediated through an increase of cAMP. This is again in contrast to the action of cholera toxin, in which the inhibitory action has been associated with such a rise (8, 9) . Nakamura and Ui (29) have reported that cAMP does not appear to play a role in the inhibition of stimulated histamine release in rat mast cells treated with pertussis toxin. These findings suggest that in both the mast cell and in the neutrophil, the N protein acted upon by pertussis toxin may not be coupled to adenylate cyclase.
Our ignorance as to the nature of the putative GTP-binding regulatory protein that is the presumed target of the pertussis toxin extends to the general nature of the process that is inhibited. There are at present two possibilities. The first is that the toxin, in reacting with its presumed neutrophil N protein, interferes with the inhibition by that activated N protein of some receptor-mediated process; this would be analogous to the manner in which the toxin in other cells interacts with N~ to prevent its inhibition ofadenylate cyclase. The second possibility is that the toxin, in interacting with N protein, prevents its activation of some necessary process; the analogy here is the way pertussis toxin prevents retinal transducin from activating the cGMP phosphodiesterase (1).
This work, although throwing no light on the function of the target of toxin action other than providing some examples of what it is not, clearly pinpoints the area in the process of neutrophil activation where this function is exerted. At present, most investigators believe that chemotactic factors such as fMet-Leu-Phe, C5a, LTB4, etc., activate neutrophils through, among other things, the combined action of a rise in cytosolic Ca 2÷ with its resultant reactions, and the activation of protein kinase C and the reactions that ensue from this. The lack of effect of pertussis toxin on the granule enzyme release induced by PMA indicates that the action of pertussis toxin does not involve the sequence of reactions initiated by the activation of protein kinase C.
Treatment of the cell with toxin also does not affect granule enzyme release initiated by the influx of Ca 2÷ caused by the Ca 2+ ionophore, A23187. This is consistent with the conclusion that the final locus of toxin action is at one or more of the reactions that occur between chemotactic receptor stimulation and the resultant rise in intracellular Ca 2+. This conclusion is also fully supported by our recent finding that the rise in intracellular Ca 2÷ induced by fMet-Leu-Phe or LTB4 is greatly reduced or abolished in pertussis toxin-treated neutrophils (30) . Which reaction or reactions is the ultimate target of toxin action in the sequence that precedes the rise in intracellular Ca 2÷ is presently under study. In the course of this study, we have recently found (31) that the addition of pertussis toxin to rabbit neutrophils inhibits the fMet-LeuPhe-induced rises in Na + influx, intracenular pH, and the stimulated changes in polyphosphoinositides and the phosphorylation of a 46-kD protein. Unlike the effect of fMetLeu-Phe, the increases in Na + influx and intraceUular pH produced by PMA are not inhibited by the toxin. Also in accordance with the present results is the recent observation that exposure of guinea pig neutrophils to pertussis toxin results in a marked inhibition of the arachidonic acid release from these cells that occurs after chemotactic factor stimulation (referred to in references 21 and 29; see also references 32 and 33). After this manuscript was submitted, Okajima and Ui (32) and Bokoch and Gilman (33) published conclusions similar to those researched here.
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